Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Kura Oncology
Kura Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?